Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
US Patent 20040151708 A1: Strain of Micro-organism lactobacillus fermentum me-3 as novel anti-microbial and anti-oxidative probiotic
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
Brown might not have been sanctioned and might still be abusing athletes
This is your countdown clock
Are points awarded on discounted products
US$ 23.48
US$ 25.82
US$ 23.56
US$ 23.01
US$ 21.96
US$ 26.08
